HIV-1 suppression during acute scrub-typhus infection

Lancet

Volumn 356, Issue 9228, 2000, Pages 475-479

  Watt, George ^a   Kantipong, Pacharee ^b   De Souza, Mark ^a   Chanbancherd, Penprapa ^c   Jongsakul, Krisada ^a   Ruangweerayud, Ronnatrai ^d   Loomis Price, Lawrence D ^e   Polonis, Victoria ^a   Saw Myint, Khin ^a   Birx, Deborah L ^e   Brown, Arthur E ^a   Krishna, Sanjeev ^f  

^a ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^b Chiang Rai Prachanukhro Hospital   (Thailand)

^c Army Institute of Pathology   (Thailand)

^d MAE SOT GENERAL HOSPITAL   (Thailand)

^e WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^f ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOFLUORESCENCE; LYMPHOCYTE COUNT; MALE; ORIENTIA TSUTSUGAMUSHI; PRIORITY JOURNAL; SCRUB TYPHUS; VIRUS LOAD;

EID: 0034609287     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02557-5     Document Type: Article

References (23)

1. Karp C.L., Neva F.A. Tropical infectious diseases in human immunodeficiency virus-infected patients. Clin Infect Dis. 28:1999;947-965.
2. Kantipong P., Watt G., Jongsakul K., Choenchitra C. Infection with human immunodeficiency virus does not influence the clinical severity of scrub typhus. Clin Infect Dis. 23:1996;1168-1170.
3. Watt G., Strickman D., Kantipong P., Jongsakul K., Paxton H. Prospective evaluation of a dotblot immunoassay for the rapid diagnosis of scrub typhus. J Infect Dis. 177:1998;800-802.
4. Winslow W.E., Merry D.J., Pirc M.L., Devine P.L. Evaluation of a commercial enzyme-linked immunosorbent assay for detection of immunoglobulin M antibody in diagnosis of human leptospiral infection. J Clin Microbiol. 35:1997;1938-1942.
5. Artenstein A.W., VanCott T.C., Mascola J.et al. Dual infection with human immunodeficiency virus type 1 of distinct envelope subtypes in humans. J Infect Dis. 171:1995;805-810.
6. DAIDS virology manual for HIV laboratories. NIH publicaton NIH-97-3828. 1997;US Department of Health and Human Services, Washington, DC.
7. Nara P.L., Fischinger P.J. Quantitative infectivity assay for HIV-1 and -2. Nature. 332:1988;70.
8. Zolla-Pazner S., Alving C., Belshe R.et al. Neutralization of a clade B primary isolate by sera from human immunodeficiency virus-uninfected recipients of candidate AIDS vaccines. J Infect Dis. 175:1997;764-774.
9. Watt G., Chouriyagune C., Ruangweerayud R.et al. Scrub typhus infections poorly responsive to antibiotics in Northern Thailand. Lancet. 348:1996;86-89.
10. Report of the NIH and panel to define principles of therapy of HIV infection. Ann Intern Med, 128: 1057-1078.
11. McGuire W., D'Alessandro I., Olaley B.O.et al. C-reactive protein and haptoglobin in the evaluation of a community-based malaria control program. Trans R Soc Trop Med Hyg. 90:1996;10-14.
12. Sulkowski M.S., Chaisson R.E., Karp C.L.et al. The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults. J Infect Dis. 178:1998;1642-1648.
13. Mole L., Ripich S., Margolis D., Holiday M. The impact of active herpes simplex virus infection of human immunodeficiency virus load. J Infect Dis. 176:1997;766-770.
14. Brichacek B., Swindells, Janoff E.N.et al. Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine. J Infect Dis. 174:1996;1191-1199.
15. Ortigao-de-Sampaio, Shattock R.J., Hayes P.et al. Increase in plasma viral load after oral cholera immunization of HIV-infected subjects. AIDS. 12:1998;F145-F150.
16. Garcia F., Vidal G., Gatell J.M.et al. Changes in HIV-1 RNA viral load following tuberculin skin test. J Acquir Immune Defic Syndr. 18:1998;398-399.
17. Oaks E.V., Rice R.M., Kelly D.J., Stover C.K. Antigenic and genetic relatedness of eight Rickettsia tsutsugamushi antigens. Infect Immun. 57:1989;3116-3122.
18. Mellors J.W., Munoz A., Giorgi J.V.et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med. 126:1998;946-954.
19. Xiao L., Owen S.M., Rudolph D.L., Lal R.B., Lal A.A. Plasmodium falciparum antigen-induced immunodeficiency virus type 1 replication is medicated through induction of tumor necrosis factor-α J Infect Dis. 177:1998;437-445.
20. Newman G.W., Adams D.L., Maslow J.N., Murphy-Corb M., Didier P.J. Differential tumor necrosis factor alpha production in simian immunodeficiency virus-infected rhesus macaques coinfected with Mycobacterium avium. Clin Infect Dis. 28:1999;514-519.
21. Richmann D.D., Bozzette S.A. The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. J Infect Dis. 169:1994;968-974.
22. Colin J.F., Cazals-Hatem D., Loriot M.A.et al. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology. 4:1999;1306-1310.
23. Bloom B.R. The highest attainable standard. ethical issues in AIDS vaccines Science. 268:1998;516-519.